SNDX

SYNDAX PHARMACEUTICALS INC

Healthcare | Mid Cap

-$0.54

EPS Forecast

$73.67

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

-$0.54

Revenue Forecast:

$73.67

EPS Surprise Forecast:

$0.012

Revenue Surprise Forecast:

$4

Post-release price volatility - High

Post-release Overnight Move:

±9.3%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

57%

Probability of beating revenue consensus:

75%

Probability of beating both EPS & revs consensus:

48%

Probability of missing both EPS & revs consensus:

15%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-1

Beta (β)

Forward Looking Beta (β):

1.07

Earnings volatility

EPS standard deviation:

$0.22

Revenue standard deviation:

$13

As % of share price:

0.93% HIGH

As % of market cap:

0.61% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

-$0.25

Revenue 95th %ile:

$90

EPS 75th %ile:

-$0.46

Revenue 75th %ile:

$78

EPS 25th %ile:

-$0.60

Revenue 25th %ile:

$70

EPS 5th %ile:

-$0.79

Revenue 5th %ile:

$60

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

37% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

56% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$23

Bid-ask per Share:

$0.055